Advocate editorial board opinion: Fox's legacy will lead to a cure or management of disease
By the Advocate Editorial Board
Aug. 18, 2011 at 3:18 a.m.
When we heard of Craig Fox's passing, a pall of quiet fell over our newsroom.
Fox, who suffered from the disease amyotrophic lateral sclerosis, died Wednesday afternoon after battling the malady for about four years.
Many of us at the Advocate never met Fox or were fortunate to hear his philosophy on life first hand. But we read the stories and heard the documentary and videos. All of us were amazed at his vivacious approach to life - he considered life a gift - and how he gently, tenderly and passionately loved his family, who likewise returned that powerful love threefold.
Fox insisted that it was important to be able to laugh at oneself. We think everybody should embrace that philosophy.
The world would be a better place if we were able to recognize our foibles, and deal with them openly.
Fox so wanted others afflicted with ALS to have a better chance in life that he agreed to interviews and filming, bringing the disease out of its dark hiding place of obscurity to the light of knowledge - not only in our community but across the country.
So the Advocate followed him, learned how he lived, how he loved and his view of life. And many of us became like family to him.
In our profession, we call it narrative journalism when a subject invites reporters into their lives to document how they live.
In this case, we not only learned about Fox and his family, we learned about this horrible disease that has no cure, that claims its victims within five years and that has not had enough attention to spur research for a cure or for, at the very minimum, medicine that would help to manage and prevent it from progressing.
Yes, Fox - and his family - have brought ALS in the light.
They leave a potent legacy that will be built upon - and that will spell the end of ALS. For this, we thank him and his family and share in your loss.
This editorial reflects the views of the Victoria Advocate's editorial board.